• Saturday, August 11, 2018 @ 12:00 am

ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy, today announced that the company management will participate in the Wedbush PacGrow Healthcare Conference taking place on August 14-15, 2018, in New York City. 

ObsEva's presentation will take place on Tuesday, August 14th, 2018, at 8:00 a.m. Eastern Time (ET).  A webcast will be available in the "Investors" section of ObsEva's website www.ObsEva.com.